122 related articles for article (PubMed ID: 12738387)
1. Orogastric vaccination of guinea pigs with Helicobacter pylori sonicate and a high dose of cholera toxin lowers the burden of infection.
Durrani Z; Rijpkema S
FEMS Immunol Med Microbiol; 2003 May; 36(3):169-73. PubMed ID: 12738387
[TBL] [Abstract][Full Text] [Related]
2. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
[TBL] [Abstract][Full Text] [Related]
3. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
Keenan JI; Rijpkema SG; Durrani Z; Roake JA
FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
6. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
7. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Sijun H; Yong X
Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
[TBL] [Abstract][Full Text] [Related]
9. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
[TBL] [Abstract][Full Text] [Related]
10. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
[TBL] [Abstract][Full Text] [Related]
12. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
14. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
16. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
17. Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H pylori heparan sulphate-binding proteins coupled to cholera toxin beta-subunit.
Ruiz-Bustos E; Sierra-Beltran A; Romero MJ; Rodriguez-Jaramillo C; Ascencio F
J Med Microbiol; 2000 Jun; 49(6):535-541. PubMed ID: 10847207
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection.
Ikewaki J; Nishizono A; Goto T; Fujioka T; Mifune K
Microbiol Immunol; 2000; 44(1):29-39. PubMed ID: 10711597
[TBL] [Abstract][Full Text] [Related]
20. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]